Bouchal Jan Ph.D., Assoc. Prof.

Phone: +420 585632451

Groups: AFFILIATED STAFF, PATHOLOGY

https://www.webofscience.com/wos/author/record/1649059

BOUCHALOVÁ, K., M. SVOBODA, G. KHARAISHVILI, J. VRBKOVÁ, J. BOUCHAL, R. TROJANEC, V. KOUDELÁKOVÁ, L. RADOVÁ, K. CWIERTKA, M. HAJDÚCH, Z. KOLÁŘ

BCL2 is an independent predictor of outcome in basal-like triple-negative breast cancers treated with adjuvant anthracycline-based chemotherapy. Tumor Biology. 2015, 36(6), 4243-52, ISSN: 1010-4283, PMID: 25616695,

BURDOVA, A., J. BOUCHAL, S. TAVANDZIS, Z. KOLÁŘ

TMPRSS2-ERG gene fusion in prostate cancer. Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic. 2014, 158(4), 502-510, ISSN: 1213-8118, PMID: 25485532,

BOUCHALOVÁ, K., G. KHARAISHVILI, J. BOUCHAL, J. VRBKOVÁ, M. HOUDOVÁ MEGOVÁ, A. HLOBILKOVA

Triple negative breast cancer-BCL2 in prognosis and prediction. Review. Current Drug Targets. 2014, 15(12), 1166-1175, ISSN: 1389-4501, PMID: 25374001,

Bouchal Jan Ph.D., Assoc. Prof.

About me

Journals